Oncolytics Biotech (ONCY) Other financing activities (2009 - 2023)

Oncolytics Biotech (ONCY) has 14 years of Other financing activities data on file, last reported at $275450.8 in Q4 2023.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $275450.8 in Q4 2023; TTM through Dec 2023 was $322444.4, a 3303.57% increase from a year earlier, with the FY2025 full-year figure at -$27000.0, down 157.45% from the prior year.
• Other financing activities for Q4 2023 stood at $275450.8, up from $46993.6 in the prior quarter.
• Over the last five years, Other financing activities for ONCY reached as high as $4.5 million in Q3 2019 and fell as low as $3840.2 in Q3 2021.
• Historically, Other financing activities has averaged $473442.7 across 5 years, with a median of $46993.6 in 2023.
• Across the five-year window, Other financing activities jumped 5032.73% in 2019 and plunged 93.67% in 2022, its largest moves.
• Year by year, Other financing activities stood at $4.5 million in 2019, then plunged by 97.65% to $106016.2 in 2020, then tumbled by 72.27% to $29393.1 in 2021, then tumbled by 67.77% to $9473.7 in 2022, then jumped by 2807.53% to $275450.8 in 2023.
• Per Business Quant data, the three most recent Other financing activities figures were $275450.8 in Q4 2023, $46993.6 in Q3 2023, and $9473.7 in Q1 2022.